AstraZeneca Pharma India gets Dapagliflozin 10mg import and market permission from CDSCO
AstraZeneca Pharma India has secured an import and market permission for Dapagliflozin (Forxiga) tablets of 10 mg from India’s Central Drugs Standard Control Organisation (CDSCO), ... Read More
AstraZeneca India scraps Dapagliflozin distribution deal with Abbott
AstraZeneca Pharma India (AstraZeneca India) said that it has scrapped its distribution agreement with Abbott Healthcare pertaining to its Type 2 diabetes drug Dapagliflozin in ... Read More